LB Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on the development of innovative therapies for neuropsychiatric disorders, including schizophrenia and bipolar depression. With a strong commitment to addressing unmet medical needs in mental health, the company leverages cutting-edge research to advance its drug candidates through clinical trials. Headquartered in New York, NY, LB Pharmaceuticals aims to transform the treatment landscape for patients suffering from complex psychiatric conditions.